Executive Summary For decades, neuropsychiatry was a field characterized by high failure rates and incremental progress, making it a challenging...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to...

- Dosing is underway in the Phase 3 CYB003 PARADIGM program which comprises two 12-week randomized, double-blind, placebo-controlled studies (APPROACH™...

Table of Contents Understanding the 2025 Threat Landscape: Why Every Small Business Is a Target Building a Resilient Foundation: A...

Investors looking into Take-Two Interactive stock returns are witnessing a compelling investment story, especially over the past two decades.With a...

Tokenized government debt is becoming increasingly prominent as a financial innovation, particularly within the crypto markets.By transforming traditional government bonds...

Nektar Therapeutics has made headlines today as its stock surged by an impressive 30.3%, reaching a price of $12.44 during...

Elon Musk's insights on AI politics highlight a significant disconnect between technological advancements and governmental response mechanisms.At the AI Startup...

Crypto journalism is at a pivotal moment, particularly with the recent partnership between Cointelegraph and Nansen, a leader in blockchain...

June 16, 2025 8:00 AM EDT | Source: Universal Digital Inc. Targets Launching Bitcoin Treasuries in Asia's US$25 Trillion Public Market...